Skip to main content
Journal cover image

Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020.

Publication ,  Journal Article
Marx, N; Ryden, L; Brosius, F; Ceriello, A; Cheung, M; Cosentino, F; Green, J; Kellerer, M; Koob, S; Kosiborod, M; Prashant Nedungadi, T ...
Published in: Diabetes Res Clin Pract
July 2021

In June 2020, the Taskforce of the Guideline Workshop 2019 convened via teleconferencing to initiate a pilot project that demonstrates the various processes and considerations involved in developing high-quality, evidence-based clinical practice guidelines for the medical management of individuals with type 2 diabetes (T2D) and its associated comorbidities, including cardiovascular disease (CVD) and chronic kidney disease (CKD). The goal of the pilot project was to create evidence-based guidelines for use of sodium-glucose transport protein 2 inhibitors (SGLT2-I) when managing very high risk T2D patients, evidenced by the presence of both CVD and CKD. For this purpose the Taskforce represented a guideline panel and made use of synthesized evidence from an ongoing BMJ Rapid Recommendations project on SGLT2-I and GLP-1 receptor agonists. Results from the Taskforce pilot project demonstrated the value, feasibility and utility of using a step-wise approach to identifying and grading evidence and then developing actionable recommendations for utilizing SGLT2-I in this at-risk T2D population. This report describes the various steps involved in the process and explains how it can be utilized to rapidly develop recommendations in a format that is easy to use and can be quickly updated as new evidence becomes available, also within the emerging concept of living guidelines.

Duke Scholars

Published In

Diabetes Res Clin Pract

DOI

EISSN

1872-8227

Publication Date

July 2021

Volume

177

Start / End Page

108870

Location

Ireland

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium-Glucose Transport Proteins
  • Practice Guidelines as Topic
  • Pilot Projects
  • Hypoglycemic Agents
  • Humans
  • Endocrinology & Metabolism
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • 5203 Clinical and health psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marx, N., Ryden, L., Brosius, F., Ceriello, A., Cheung, M., Cosentino, F., … Schnell, O. (2021). Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020. Diabetes Res Clin Pract, 177, 108870. https://doi.org/10.1016/j.diabres.2021.108870
Marx, Nikolaus, Lars Ryden, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, et al. “Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020.Diabetes Res Clin Pract 177 (July 2021): 108870. https://doi.org/10.1016/j.diabres.2021.108870.
Marx N, Ryden L, Brosius F, Ceriello A, Cheung M, Cosentino F, et al. Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020. Diabetes Res Clin Pract. 2021 Jul;177:108870.
Marx, Nikolaus, et al. “Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020.Diabetes Res Clin Pract, vol. 177, July 2021, p. 108870. Pubmed, doi:10.1016/j.diabres.2021.108870.
Marx N, Ryden L, Brosius F, Ceriello A, Cheung M, Cosentino F, Green J, Kellerer M, Koob S, Kosiborod M, Prashant Nedungadi T, Rodbard HW, Vandvik PO, Ji L, Sheu WH-H, Standl E, Schnell O. Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020. Diabetes Res Clin Pract. 2021 Jul;177:108870.
Journal cover image

Published In

Diabetes Res Clin Pract

DOI

EISSN

1872-8227

Publication Date

July 2021

Volume

177

Start / End Page

108870

Location

Ireland

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium-Glucose Transport Proteins
  • Practice Guidelines as Topic
  • Pilot Projects
  • Hypoglycemic Agents
  • Humans
  • Endocrinology & Metabolism
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • 5203 Clinical and health psychology